Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

AbbVie shares promising phase 3 results for Rinvoq in severe alopecia areata

Around 700,000 people in the US are living with some form of the autoimmune disease

- PMLiVE

Celebrating the Cannes Lions International Festival of Creativity

Cannes’ most forward-looking conversations weren’t about pharma – but pharma should have been listening

New team members

Cuttsy+Cuttsy welcomes new team members

Cuttsy+Cuttsy is excited to announce the addition of three talented professionals to the team: Flo, an enthusiastic Account Executive; Vicki, a creative Graphic Designer; and Jo, a detail-driven Artworker

Cuttsy + Cuttsy

Unlocking the future of Learning

By Potter Li and Aaron Fletcher

Amiculum

- PMLiVE

Medical Misinformation and Sensationalism in the Age of Social Media

In today’s digital age, misinformation spreads faster than ever, often driven by sensational headlines and influencer content. These sources of misinformation often overshadow evidence-based content, creating confusion for both healthcare...

Medscape Education

- PMLiVE

Novo Nordisk’s Alhemo approved by FDA for expanded haemophilia use

The rare bleeding disorder affects approximately 800,000 people globally

Biogen Idec building

Biogen/Eisai’s Alzheimer’s drug Leqembi shows continued benefit over four years

An estimated 13 million people in the US will be living with Alzheimer’s disease by 2050

- PMLiVE

Embracing uncertainty in precision medicine communications for lung cancer

By Jessica Hurley

- PMLiVE

FDA unveils PreCheck programme to enhance US domestic pharma supply chain

The new initiative was developed in response to President Donald Trump's executive order

- PMLiVE

Eli Lilly’s Mounjaro shown to provide cardiovascular protection in type 2 diabetes patients

Approximately 38.4 million people in the US are affected by diabetes

- PMLiVE

Patient activation: time to think differently about treatments…

By Rob Horne and Alf Collins

- PMLiVE

Patient Recruitment in Oncology: A Phase III Melanoma Case Study

Boosting screening & enrollment rates in a global oncology trial

Innovative Trials

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links